Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingyun Su

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Molecular Carcinogenesis|August 20, 2025
Independent Clonal Origin in Early-Stage Bilateral Papillary Thyroid Cancer: Evidence From Nuclear and Mitochondrial Genome AnalysisXingyun Su, Jimeng Yuan, Xianmeng Chen, et al.
International Journal of Molecular Sciences|October 14, 2016
A Comprehensive Characterization of Mitochondrial Genome in Papillary Thyroid CancerXingyun Su, Weibin Wang, Guodong Ruan, et al.
Endocrine|February 27, 2019
Clonal analysis of early-stage bilateral papillary thyroid cancer identifies field cancerizationXingyun Su, Shitu Chen, Kuifeng He, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2024
Preoperative Serum Lipids as Novel Predictors of Survival in 3575 Patients With Papillary Thyroid CancerJimeng Yuan, Zhendong Chen, Jing Zhang, et al.
Cancers|October 27, 2022
Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy EfficacyYulong Zheng, Qiqi Gao, Xingyun Su, et al.
Endocrine-Related Cancer|May 15, 2023
BRAFV600E restructures cellular lactylation to promote anaplastic thyroid cancer proliferationXumeng Wang, Tianxing Ying, Jimeng Yuan, et al.
Cancer|October 28, 2015
Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patientsWeibin Wang, Xingyun Su, Kuifeng He, et al.
Frontiers in Endocrinology|March 8, 2021
Thyroid Function Abnormalities in COVID-19 PatientsWeibin Wang, Xingyun Su, Yongfeng Ding, et al.
Translational Oncology|January 9, 2020
VCAM-1 Upregulation Contributes to Insensitivity of Vemurafenib in BRAF-Mutant Thyroid CancerShitu Chen, Xingyun Su, Xiaoxia Jiang, et al.
Frontiers in Oncology|May 26, 2022
Preoperative Thyroid Peroxidase Antibody Predicts Recurrence in Papillary Thyroid Carcinoma: A Consecutive Study With 5,770 CasesWeibin Wang, Liping Wen, Shitu Chen, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Molecular Carcinogenesis|August 20, 2025
Independent Clonal Origin in Early-Stage Bilateral Papillary Thyroid Cancer: Evidence From Nuclear and Mitochondrial Genome AnalysisXingyun Su, Jimeng Yuan, Xianmeng Chen, et al.
International Journal of Molecular Sciences|October 14, 2016
A Comprehensive Characterization of Mitochondrial Genome in Papillary Thyroid CancerXingyun Su, Weibin Wang, Guodong Ruan, et al.
Endocrine|February 27, 2019
Clonal analysis of early-stage bilateral papillary thyroid cancer identifies field cancerizationXingyun Su, Shitu Chen, Kuifeng He, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2024
Preoperative Serum Lipids as Novel Predictors of Survival in 3575 Patients With Papillary Thyroid CancerJimeng Yuan, Zhendong Chen, Jing Zhang, et al.
Cancers|October 27, 2022
Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy EfficacyYulong Zheng, Qiqi Gao, Xingyun Su, et al.
Endocrine-Related Cancer|May 15, 2023
BRAFV600E restructures cellular lactylation to promote anaplastic thyroid cancer proliferationXumeng Wang, Tianxing Ying, Jimeng Yuan, et al.
Cancer|October 28, 2015
Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patientsWeibin Wang, Xingyun Su, Kuifeng He, et al.
Frontiers in Endocrinology|March 8, 2021
Thyroid Function Abnormalities in COVID-19 PatientsWeibin Wang, Xingyun Su, Yongfeng Ding, et al.
Translational Oncology|January 9, 2020
VCAM-1 Upregulation Contributes to Insensitivity of Vemurafenib in BRAF-Mutant Thyroid CancerShitu Chen, Xingyun Su, Xiaoxia Jiang, et al.
Frontiers in Oncology|May 26, 2022
Preoperative Thyroid Peroxidase Antibody Predicts Recurrence in Papillary Thyroid Carcinoma: A Consecutive Study With 5,770 CasesWeibin Wang, Liping Wen, Shitu Chen, et al.
Pageof 2